Novo’s CagriSema shot was shown to be less effective than rival Lilly’s tirzepatide ...

When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the ...

Blinded, Sham-Controlled Study Designed to be Executed in Collaboration with Lindus Health to Support Future FDA Submission ...

The trouble with FDA's move to require only one study for new drugs ...

Researchers at The Hospital for Sick Children (SickKids), working with international collaborators and youth and family ...

Randomized, blinded clinical study evaluating injectable autologous hair follicle secretome in patients with androgenic ...

In the Phase 2 S-OLARIS clinical trial in axial spondyloarthritis (axSpA), sonelokimab (SLK) demonstrated clinically meaningful benefit with 80+% ...

Last week, the FDA made its one pivotal trial policy official, sparking myriad questions from industry leaders, including around specific evidence required for the single study and why it hasn’t been ...

A new study published in the journal of BMC Nephrology revealed that home-based Otago exercise is a safe, low-cost, and ...

GRAIL's topline results from the NHS-Galleri trial were a clear disappointment with no major implications on ...

A new clinical trial has found that a multi-ingredient longevity supplement may help improve key markers of vascular aging, such as arterial flexibility and healthy blood pressure support.